CSIMarket Company Name, Ticker, Competitors, else..


Allogene Therapeutics Inc   (NASDAQ: ALLO)
Other Ticker:  
 

Allogene Therapeutics Inc

ALLO's Fundamental analysis



Allogene Therapeutics Inc 's sales fell in the first quarter of 2025 from the same quarter a year ago.

Biotechnology & Pharmaceuticals industry recorded growth of revenues by 11.96 %

Allogene Therapeutics Inc net loss decreased from $-65 millions, to $-60 millions in first quarter of 2025,

• More on ALLO's Growth


Allogene Therapeutics Inc
realized a net loss in trailing twelve months.

Allogene Therapeutics Inc realized cash reduction of $ -0.04 per share in trailing twelve-month period.
Company
-
PE TTM   
Industry
-
PE TTM    
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 6.02.


• More on ALLO's Valuation
 
 Total Debt (Millions $) -
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ -
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) -
 Tangible Book Value (Per Share $) 1.79

Allogene Therapeutics Inc
realized net loss in trailing twelve months.

Allogene Therapeutics Inc realized cash outflow of $ -0.04per share in trailing twelve-month period.
Company
-
PE TTM   
Industry
-
PE TTM    
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 6.02.

Allogene Therapeutics Inc Price to Book Ratio is at 0.62 higher than Industry Avg. of -23410.1, and higher than S&P 500 Avg. of 0.01

• More on ALLO's Valuation

•  Market Capitalization (Millions $) 239
•  Shares Outstanding (Millions) 215
•  Employees 229
•  Revenues (TTM) (Millions $) -
•  Net Income (TTM) (Millions $) -252
•  Cash Flow (TTM) (Millions $) -9
•  Capital Exp. (TTM) (Millions $) -1
•  Total Debt (Millions $) -
•  Dividend TTM ($) 0 $
•  Dividend Yield TTM (%) -
•  Revenue/Employee (TTM) $ -
•  Net Income/Employee(TTM) $ -
•  Receivable Turnover Ratio (TTM) -
•  Tangible Book Value (Per Share $) 1.79

•  Market Capitalization (Millions $) 239
•  Shares Outstanding (Millions) 215
•  Employees 229
•  Revenues (TTM) (Millions $) -
•  Net Income (TTM) (Millions $) -252
•  Cash Flow (TTM) (Millions $) -9
•  Capital Exp. (TTM) (Millions $) -1





  Ratio
•   Capital Ratio (MRQ) 9.71
•  Total Debt to Equity (MRQ) -
•  Tangible Leverage Ratio (MRQ) 0.32
•  Asset Turnover Ratio (TTM) -
•  Inventory Turnover Ratio (TTM) -





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com